Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerin Medical, Audere, Bioinnovation Institute, Boomerang, Ferring, Guardant, Humancyte, Lucid Diagnostics, Lumicell, Mend Nutrition, Opgen, Sapphiros.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acadia, Alkermes, Altemia, Araris, ARS, Awakn, Coeptis, Daewoong, Deverra, Lobe, Nektar, Neophore, Neuren, Sygnature, Tiziana.

Additional early-stage research and drug discovery news in brief, from: Dragonfly Therapeutics, Enanta Pharmaceuticals, Enanta Pharmaceuticals, Kura Oncology, Telix Pharmaceuticals, Tonix Pharmaceuticals.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott Laboratories, Bio-Techne, Bracco Imaging, Dexcom, Excellus Communications, Fresenius, Livecare, Lunaphore, Quest Diagnostics, Radiopharm, Sonothera, Terthera.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Affini-T, Akthelia, Argenx, Athenex, Biomed, Caris, Eisai, Enzolytics, Flare, Genmab, Geovax, Gilead, Graf, Navidea, Meilleur, Nkgen, Smart Immune.

Additional early-stage research and drug discovery news in brief, from: Bioaegis Therapeutics, Evaxion Biotech, Jubilant Therapeutics, Sana Biotechnology.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerwave, Autonomous Medical, Avita, Caregility, Keygene, Lucius Partners, Pillar Biosciences, Xandar Kardian.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Clinical Laserthermia Systems, Neuronetics, Tivic Health Systems.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bluebird, Crispr, Dyadic, Essa, Genequantum, Ginkgo, ICER, Imaginab, Insilico, Intercept, J&J, Leucid, Madrigal, Merck & Co., Microbiota, Pyramid, Tiziana, Vertex, Xenetic.

Additional early-stage research and drug discovery news in brief, from: Byondis, Zyversa Therapeutics.